Research grants endowed with €240,000 each DKMS Funds blood cancer research – call For applications launched

510

Scientists with a research focus on stem cell transplantation and cell therapy are invited to apply for the 2023 DKMS John Hansen Research Grant starting August 10, 2022. With this grant, the DKMS Stiftung Leben Spenden (Foundation for Giving Life) supports up to four outstanding research projects each year that aim to advance the medical progress and improve the chances of recovery for blood cancer patients. The requirements include a doctoral degree (PhD, MD or equivalent) that was obtained no longer than 10 years ago. The grants are endowed with €240,000 each, which will be paid out over a period of three years. The application deadline is December 2, 2022.

In India, DKMS operantes as DKMS BMST Foundation India, which is a joint venture with BMST (Bangalore Medical Services Trust). DKMS-BMST was officially launched on 28th May 2019 with a mission to give every blood cancer and blood disorder patient in need with a second chance at life. Since its launch, DKMS-BMST has organized over 1300 donor registration events across various organisations such as corporates, educational institutes, hospitals and defence forces to raise awareness about blood stem cell donation and enrol more potential donors. So far, DKMS-BMST has successfully registered over 70,000 potential blood stem cell donors from India and provided 64 patients with a second chance at life.

Every year, more than 1.3 million people worldwide are diagnosed with blood cancer. A blood stem cell transplantation saves the lives of many of them. However, by far not all patients are permanently cured afterwards. Relapses and severe complications, especially graft-versus-host disease, still pose a great challenge for medicine and science. 

Therefore, DKMS is committed to medical progress beyond its original tasks as a stem cell donor center. An important pillar of this commitment is the promotion of young scientists. “Our goal is to help as many patients as possible, across the globe,” says Professor Dr. Marcel van den Brink, Chairman of the DKMS Medical Council. “To achieve this goal, we must continue to develop and improve stem cell transplantation and other cellular therapies. It is therefore vital that the best research in this field is secured for the future. We are very pleased to be able to contribute towards this with the DKMS John Hansen Research Grant, which supports research by talented early career physicians and scientists.”

All information about the application modalities and further details about the DKMS John Hansen Research Grant are available on the DKMS Professionals’ Platform. If you have any questions, you are also welcome to email DKMS at grant@dkms.org. 

DKMS: More than 100,000 second chances at life

DKMS is known as one of the world’s leading stem cell donor centers. More than 11 million potential stem cell donors are registered with DKMS. To date, DKMS has already enabled more than 100,000 second chances at life. In addition, the non-profit organization operates its own research unit in Dresden and, with the DKMS Life Science Lab, has one of the most powerful HLA typing laboratories in the world. Since the beginning of 2020 alone, DKMS research teams have launched nine innovative scientific studies. Those who would like to find out more about the scientific commitment of the non-profit organization can find detailed information on the DKMS Professionals’ Platform. 

John A. Hansen – outstanding physician with a big heart

John A. Hansen, after whom the grant is named, was an outstanding oncologist and distinguished immunogeneticist at the renowned Fred Hutchinson Cancer Research Center in Seattle. With his excellent achievements in the field of hematopoietic stem cell transplantation, this dedicated and empathetic physician made a significant contribution to increasing the efficacy and safety of blood stem cell and bone marrow transplantations – and thus gave numerous patients a second chance at life. As a long-standing member of the board of the DKMS Stiftung Leben Spenden and a member of the DKMS Medical Council, he was deeply connected to the DKMS family.

The DKMS Stiftung Leben Spenden

DKMS Stiftung Leben Spenden is the wholly owned parent company of DKMS gGmbH and the entire international DKMS Group. You can find more information about the foundation here. 

ALSO READ : FedEx and Junior Achievement Support Future Entrepreneurs: Winners of the 16th Annual FedEx / JA International Trade Challenge Announced

About DKMS

DKMS is an international non-profit organization dedicated to saving the lives of patients with blood cancer and blood disorders. Founded in Germany in 1991 by Dr. Peter Harf, DKMS and the organization’s over 1,000 employees have since relentlessly pursued the aim of giving as many patients as possible a second chance at life. With over 11 million registered donors, DKMS has succeeded in doing this more than 100,000 times to date by providing blood stem cell donations to those in need. This accomplishment has led to DKMS becoming the global leader in the facilitation of unrelated blood stem cell transplants. The organization has offices in Germany, the US, Poland, the UK, Chile and South Africa. In India, DKMS has founded the joint venture DKMS-BMST together with the Bangalore Medical Services Trust. International expansion and collaboration are key to helping patients worldwide because, like the organization itself, blood cancer knows no borders.

DKMS is also heavily involved in the fields of medicine and science, with its own research unit focused on continually improving the survival and recovery rate of patients. In its high-performance laboratory, the DKMS Life Science Lab, the organization sets worldwide standards in the typing of potential blood stem cell donors.

Top Courses in Computer Science Engineering

Top Courses in Food and Nutrition

Loading...

More Courses With Certification

About DKMS BMST Foundation India

A non-profit organization dedicated to the fight against blood cancer and other blood disorders, such as thalassemia and aplastic Anemia. Our aim is to improve the situation of patients suffering from blood cancer and other blood disorders in India and throughout the world, by raising awareness about blood stem cell transplantation and registering potential blood stem cell donors. By doing this DKMS-BMST provides patients in need of a blood stem cell transplant with a second chance at life. 

DKMS-BMST is a joint venture of two reputed non-profit organizations: BMST (Bangalore Medical Services Trust) and DKMS, one of the largest international blood stem cell donor centres in the world

Visit EasyShiksha for new updates.

Download this article as PDF to read offline: